CHE RSI Chart
Last 7 days
2.7%
Last 30 days
-8.1%
Last 90 days
-2.4%
Trailing 12 Months
4.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.3B | 0 | 0 | 0 |
2023 | 2.2B | 2.2B | 2.2B | 2.3B |
2022 | 2.1B | 2.1B | 2.1B | 2.1B |
2021 | 2.1B | 2.1B | 2.1B | 2.1B |
2020 | 2.0B | 2.0B | 2.1B | 2.1B |
2019 | 1.8B | 1.9B | 1.9B | 1.9B |
2018 | 1.7B | 1.7B | 1.8B | 1.8B |
2017 | 1.6B | 1.6B | 1.6B | 1.7B |
2016 | 1.6B | 1.6B | 1.6B | 1.6B |
2015 | 1.5B | 1.5B | 1.5B | 1.5B |
2014 | 1.4B | 1.4B | 1.4B | 1.5B |
2013 | 1.4B | 1.4B | 1.4B | 1.4B |
2012 | 1.4B | 1.4B | 1.4B | 1.4B |
2011 | 1.3B | 1.3B | 1.3B | 1.4B |
2010 | 1.2B | 1.2B | 1.2B | 1.3B |
2009 | 0 | 1.2B | 1.2B | 1.2B |
2008 | 0 | 0 | 0 | 1.1B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 07, 2024 | witzeman michael d | acquired | 454,509 | 413 | 1,100 | vp & chief financial officer |
May 07, 2024 | witzeman michael d | sold (taxes) | -531,371 | 576 | -921 | vp & chief financial officer |
Apr 30, 2024 | lee spencer s | gifted | - | - | -1,133 | executive vice president |
Mar 28, 2024 | lee spencer s | sold (taxes) | -4,557,960 | 643 | -7,080 | executive vice president |
Mar 28, 2024 | lee spencer s | acquired | 1,385,670 | 106 | 13,000 | executive vice president |
Mar 28, 2024 | lee spencer s | sold | -1,283,300 | 641 | -2,000 | executive vice president |
Mar 21, 2024 | witzeman michael d | sold | -1,704,320 | 643 | -2,650 | vp & chief financial officer |
Mar 20, 2024 | judkins brian c | sold | -7,196,910 | 645 | -11,158 | vp and chief legal officer |
Mar 20, 2024 | witzeman michael d | acquired | 1,074,290 | 413 | 2,600 | vp & chief financial officer |
Which funds bought or sold CHE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | Cynosure Group, LLC | new | - | 309,410 | 309,410 | 0.06% |
May 10, 2024 | JUPITER ASSET MANAGEMENT LTD | reduced | -0.05 | 2,828,190 | 31,921,300 | 0.30% |
May 10, 2024 | VANGUARD GROUP INC | added | 0.09 | 98,205,300 | 1,092,070,000 | 0.02% |
May 10, 2024 | BlackRock Inc. | added | 3.66 | 113,728,000 | 938,235,000 | 0.02% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 1.54 | 9,535,700 | 92,708,900 | 0.02% |
May 10, 2024 | INTECH INVESTMENT MANAGEMENT LLC | reduced | -64.59 | -378,527 | 240,724 | -% |
May 10, 2024 | SILVER OAK SECURITIES, Inc | new | - | 202,576 | 202,576 | 0.03% |
May 10, 2024 | BAHL & GAYNOR INC | added | 0.53 | 935,383 | 9,962,750 | 0.06% |
May 10, 2024 | Covestor Ltd | added | 10.61 | 25,000 | 141,000 | 0.09% |
May 10, 2024 | JPMORGAN CHASE & CO | reduced | -2.43 | 10,636,500 | 160,236,000 | 0.01% |
Unveiling Chemed Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Chemed Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 466.7B | 379.5B | 30.38 | 1.23 | ||||
CI | 99.7B | 206.0B | 25.87 | 0.48 | ||||
HCA | 84.3B | 66.7B | 15.41 | 1.26 | ||||
CVS | 69.9B | 360.9B | 9.54 | 0.19 | ||||
CNC | 41.4B | 155.5B | 15.15 | 0.27 | ||||
DVA | 12.1B | 12.3B | 14.83 | 0.98 | ||||
UHS | 11.9B | 14.7B | 14.57 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.7B | 2.3B | 30.63 | 3.79 | ||||
ACHC | 6.5B | 3.0B | -578.78 | 2.19 | ||||
AMN | 2.3B | 3.5B | 16.07 | 0.66 | ||||
AMEH | 2.2B | 1.5B | 35.09 | 1.51 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.45 | 1.6 | ||||
BKD | 1.4B | 3.0B | -7.95 | 0.45 | ||||
BEAT | 52.9M | - | -3.5 | - | ||||
AMS | 19.9M | 21.3M | 37.29 | 0.93 |
Chemed Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 0.6% | 589 | 586 | 565 | 554 | 560 | 547 | 526 | 531 | 531 | 541 | 539 | 532 | 527 | 528 | 528 | 502 | 516 | 522 | 481 | 474 | 462 |
Costs and Expenses | 8.9% | 517 | 475 | 478 | 484 | 487 | 465 | 446 | 439 | 441 | 443 | 446 | 461 | 447 | 390 | 454 | 409 | 436 | 445 | 416 | 408 | 413 |
S&GA Expenses | 15.4% | 116 | 100 | 100 | 95.00 | 100 | 97.00 | 84.00 | 88.00 | 90.00 | 92.00 | 89.00 | 94.00 | 92.00 | 87.00 | 88.00 | 85.00 | 71.00 | 83.00 | 77.00 | 72.00 | 74.00 |
EBITDA Margin | 1.9% | 0.19* | 0.18* | 0.17* | 0.17* | 0.17* | 0.18* | 0.19* | 0.20* | 0.19* | 0.19* | 0.22* | 0.21* | 0.22* | 0.22* | 0.19* | 0.18* | 0.17* | 0.16* | 0.15* | - | - |
Interest Expenses | 24.3% | 0.00 | 0.00 | 0.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Income Taxes | -23.8% | 19.00 | 26.00 | 18.00 | 17.00 | 17.00 | 20.00 | 20.00 | 20.00 | 21.00 | 22.00 | 23.00 | 19.00 | 18.00 | 32.00 | 14.00 | 18.00 | 13.00 | 14.00 | 8.00 | 14.00 | 6.00 |
Earnings Before Taxes | -26.9% | 84.00 | 116 | 93.00 | 70.00 | 71.00 | 82.00 | 76.00 | 86.00 | 85.00 | 96.00 | 95.00 | 75.00 | 84.00 | 146 | 82.00 | 100 | 69.00 | 80.00 | 67.00 | 64.00 | 51.00 |
EBT Margin | 2.5% | 0.16* | 0.15* | 0.14* | 0.14* | 0.15* | 0.15* | 0.16* | 0.17* | 0.16* | 0.16* | 0.19* | 0.18* | 0.20* | 0.19* | 0.16* | 0.16* | 0.14* | 0.13* | 0.13* | - | - |
Net Income | -27.8% | 65.00 | 90.00 | 75.00 | 53.00 | 54.00 | 62.00 | 57.00 | 66.00 | 64.00 | 75.00 | 72.00 | 57.00 | 65.00 | 114 | 68.00 | 82.00 | 56.00 | 66.00 | 59.00 | 51.00 | 45.00 |
Net Income Margin | 2.7% | 0.12* | 0.12* | 0.11* | 0.10* | 0.11* | 0.12* | 0.12* | 0.13* | 0.12* | 0.13* | 0.14* | 0.14* | 0.16* | 0.15* | 0.13* | 0.13* | 0.12* | 0.11* | 0.11* | - | - |
Free Cashflow | -25.2% | 72.00 | 97.00 | 17.00 | 116 | 43.00 | 82.00 | 39.00 | 44.00 | 88.00 | 49.00 | 102 | 9.00 | 89.00 | 71.00 | 114 | 176 | 69.00 | 50.00 | 117 | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 3.6% | 1,728 | 1,668 | 1,562 | 1,505 | 1,431 | 1,442 | 1,356 | 1,313 | 1,306 | 1,343 | 1,318 | 1,384 | 1,458 | 1,435 | 1,367 | 1,291 | 1,278 | 1,268 | 1,233 | 1,094 | 1,070 |
Current Assets | 7.7% | 540 | 501 | 395 | 337 | 262 | 273 | 199 | 203 | 185 | 230 | 201 | 269 | 347 | 329 | 271 | 189 | 199 | 191 | 168 | 180 | 159 |
Cash Equivalents | 18.7% | 313 | 264 | 173 | 160 | 58.00 | 74.00 | 8.00 | 10.00 | 18.00 | 33.00 | 29.00 | 92.00 | 210 | 163 | 113 | 20.00 | 29.00 | 6.00 | 9.00 | 3.00 | 9.00 |
Inventory | -10.8% | 11.00 | 12.00 | 13.00 | 12.00 | 11.00 | 10.00 | 10.00 | 11.00 | 11.00 | 10.00 | 8.00 | 7.00 | 7.00 | 7.00 | 8.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 |
Net PPE | -0.5% | 203 | 204 | 205 | 208 | 204 | 200 | 194 | 192 | 192 | 194 | 191 | 193 | 190 | 188 | 181 | 183 | 184 | 176 | 173 | 150 | 165 |
Goodwill | 1.1% | 592 | 585 | 585 | 582 | 581 | 581 | 580 | 580 | 580 | 579 | 579 | 579 | 579 | 579 | 579 | 578 | 577 | 577 | 577 | 511 | 511 |
Liabilities | -2.9% | 544 | 560 | 543 | 553 | 551 | 643 | 635 | 628 | 639 | 719 | 538 | 513 | 529 | 534 | 566 | 540 | 594 | 542 | 560 | 476 | 482 |
Current Liabilities | -9.6% | 282 | 312 | 297 | 302 | 283 | 297 | 298 | 285 | 280 | 302 | 286 | 267 | 290 | 299 | 329 | 319 | 247 | 262 | 252 | 224 | 217 |
Long Term Debt | - | - | - | - | - | 16.00 | 93.00 | 96.00 | 112 | 120 | 185 | - | - | - | - | - | - | 160 | 90.00 | 130 | 85.00 | 100 |
LT Debt, Current | - | - | - | - | - | 5.00 | 5.00 | 5.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | 16.00 | 93.00 | 96.00 | 112 | 120 | 185 | - | - | - | - | - | - | 160 | 90.00 | 130 | 85.00 | 100 |
Shareholder's Equity | 6.8% | 1,183 | 1,108 | 1,019 | 952 | 880 | 799 | 721 | 685 | 667 | 623 | 780 | 871 | 929 | 901 | 801 | 751 | 684 | 727 | 672 | 619 | 588 |
Retained Earnings | 2.4% | 2,506 | 2,447 | 2,363 | 2,294 | 2,246 | 2,198 | 2,141 | 2,090 | 2,029 | 1,970 | 1,901 | 1,835 | 1,784 | 1,724 | 1,615 | 1,553 | 1,476 | 1,426 | 1,365 | 1,311 | 1,265 |
Additional Paid-In Capital | 4.3% | 1,399 | 1,341 | 1,254 | 1,240 | 1,186 | 1,150 | 1,100 | 1,089 | 1,064 | 1,044 | 1,008 | 1,000 | 983 | 961 | 925 | 904 | 879 | 861 | 842 | 817 | 804 |
Accumulated Depreciation | 2.9% | 365 | 355 | 348 | 342 | 338 | 336 | 338 | 330 | 326 | 318 | 311 | 307 | 299 | 293 | 289 | 281 | 279 | 270 | 264 | 259 | 254 |
Shares Outstanding | 0.5% | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | - | - |
Float | - | - | - | - | 8,050 | - | - | - | 6,872 | - | - | - | 7,332 | - | - | - | 7,056 | - | - | - | 5,635 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -22.1% | 84,549 | 108,563 | 28,927 | 132,317 | 60,492 | 100,199 | 52,017 | 56,580 | 101,090 | 63,570 | 112,988 | 25,320 | 106,719 | 86,877 | 124,590 | 188,496 | 89,326 | 63,604 | 128,738 | 35,322 | 73,585 |
Cashflow From Investing | -66.1% | -19,385 | -11,670 | -15,438 | -16,521 | -17,013 | -19,488 | -14,279 | -11,687 | -13,948 | -14,045 | -10,410 | -15,879 | -17,423 | -15,962 | -10,220 | -13,885 | -21,493 | -13,098 | -149,213 | -14,515 | -13,934 |
Cashflow From Financing | -159.2% | -15,772 | -6,085 | -263 | -13,926 | -59,551 | -14,366 | -39,597 | -53,413 | -101,877 | -45,373 | -165,955 | -127,477 | -41,815 | -21,005 | -21,981 | -183,186 | -45,040 | -53,414 | 26,218 | -26,252 | -55,714 |
Dividend Payments | -0.1% | 6,050 | 6,056 | 6,034 | 5,727 | 5,685 | 5,626 | 5,669 | 5,400 | 5,322 | 5,559 | 5,593 | 5,427 | 5,437 | 5,440 | 5,401 | 5,108 | 5,130 | 5,131 | 5,090 | 4,768 | 4,799 |
Buy Backs | -3.7% | 38,460 | 39,928 | 14,344 | - | - | 12,976 | 24,325 | 49,420 | 27,794 | 245,662 | 163,731 | 125,542 | 41,107 | 28,471 | 24,975 | 21,913 | 100,235 | 20,705 | - | 22,676 | 49,250 |
Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Consolidated Statements Of Income [Abstract] | ||
Service revenues and sales | $ 589,233 | $ 560,157 |
Cost of services provided and goods sold (excluding depreciation) | 385,127 | 370,705 |
Selling, general and administrative expenses | 115,873 | 100,095 |
Depreciation | 13,287 | 12,286 |
Amortization | 2,521 | 2,513 |
Other operating expense | 92 | 1,739 |
Total costs and expenses | 516,900 | 487,338 |
Income from operations | 72,333 | 72,819 |
Interest expense | (425) | (1,551) |
Other income/(expense) - net | 12,577 | (103) |
Income before income taxes | 84,485 | 71,165 |
Income taxes | (19,468) | (17,044) |
Net income | $ 65,017 | $ 54,121 |
Earnings Per Share: | ||
Net income | $ 4.30 | $ 3.62 |
Average number of shares outstanding | 15,121 | 14,966 |
Diluted Earnings Per Share: | ||
Net income | $ 4.24 | $ 3.58 |
Average number of shares outstanding | 15,339 | 15,110 |
Cash Dividends Per Share | $ 0.40 | $ 0.38 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 313,350 | $ 263,958 |
Accounts receivable less allowances | 177,334 | 181,511 |
Inventories | 10,712 | 12,004 |
Prepaid income taxes | 9,790 | 13,166 |
Prepaid expenses | 28,431 | 30,204 |
Total current assets | 539,617 | 500,843 |
Investments of deferred compensation plans held in trust | 117,649 | 106,126 |
Properties and equipment, at cost, less accumulated depreciation of $365,074 (2023- $354,872) | 202,784 | 203,840 |
Lease right of use asset | 131,751 | 126,387 |
Identifiable intangible assets less accumulated amortization of $51,485 (2023 - $48,965) | 88,137 | 90,264 |
Goodwill | 591,519 | 585,017 |
Other assets | 56,176 | 55,618 |
Total Assets | 1,727,633 | 1,668,095 |
Current liabilities | ||
Accounts payable | 56,203 | 64,034 |
Income taxes | 27,353 | 6,858 |
Accrued insurance | 62,055 | 58,568 |
Accrued compensation | 49,802 | 88,381 |
Accrued legal | 7,183 | 6,386 |
Short-term lease liability | 39,279 | 38,635 |
Other current liabilities | 40,099 | 49,188 |
Total current liabilities | 281,974 | 312,050 |
Deferred income taxes | 24,899 | 30,321 |
Deferred compensation liabilities | 117,550 | 104,069 |
Long-term lease liability | 106,861 | 100,776 |
Other liabilities | 12,854 | 13,003 |
Total Liabilities | 544,138 | 560,219 |
Commitments and contingencies (Note 10) | ||
STOCKHOLDERS' EQUITY | ||
Capital stock - authorized 80,000,000 shares $1 par; issued 37,297,015 shares (2023 - 37,183,681 shares) | 37,297 | 37,184 |
Paid-in capital | 1,398,733 | 1,341,273 |
Retained earnings | 2,505,892 | 2,446,925 |
Treasury stock - 22,212,667 shares (2023 - 22,148,927 shares) | (2,760,543) | (2,719,588) |
Deferred compensation payable in Company stock | 2,116 | 2,082 |
Total Stockholders' Equity | 1,183,495 | 1,107,876 |
Total Liabilities and Stockholders' Equity | $ 1,727,633 | $ 1,668,095 |
 | Mr. Kevin J. McNamara |
---|---|
 | chemed.com |
 | Healthcare Plans |
 | 14167 |